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AbstrACt
Objectives Seasonal variations in tuberculosis diagnoses 
have been attributed to seasonal climatic changes 
and indoor crowding during colder winter months. We 
investigated trends in pulmonary tuberculosis (PTB) 
diagnosis at antiretroviral therapy (ART) programmes in 
Southern Africa.
setting Five ART programmes participating in the 
International Epidemiology Database to Evaluate AIDS in 
South Africa, Zambia and Zimbabwe.
Participants We analysed data of 331 634 HIV-positive 
adults (>15 years), who initiated ART between January 
2004 and December 2014.
Primary outcome measure We calculated aggregated 
averages in monthly counts of PTB diagnoses and ART 
initiations. To account for time trends, we compared 
deviations of monthly event counts to yearly averages, and 
calculated correlation coefficients. We used multivariable 
regressions to assess associations between deviations 
of monthly ART initiation and PTB diagnosis counts from 
yearly averages, adjusted for monthly air temperatures 
and geographical latitude. As controls, we used Kaposi 
sarcoma and extrapulmonary tuberculosis (EPTB) 
diagnoses.
results All programmes showed monthly variations 
in PTB diagnoses that paralleled fluctuations in ART 
initiations, with recurrent patterns across 2004–2014. The 
strongest drops in PTB diagnoses occurred in December, 
followed by April–May in Zimbabwe and South Africa. This 
corresponded to holiday seasons, when clinical activities 
are reduced. We observed little monthly variation in ART 
initiations and PTB diagnoses in Zambia. Correlation 
coefficients supported parallel trends in ART initiations and 
PTB diagnoses (correlation coefficient: 0.28, 95% CI 0.21 
to 0.35, P<0.001). Monthly temperatures and latitude did 
not substantially change regression coefficients between 
ART initiations and PTB diagnoses. Trends in Kaposi 
sarcoma and EPTB diagnoses similarly followed changes 
in ART initiations throughout the year.
Conclusions Monthly variations in PTB diagnosis at ART 
programmes in Southern Africa likely occurred regardless 
of seasonal variations in temperatures or latitude and 
reflected fluctuations in clinical activities and changes in 
health-seeking behaviour throughout the year, rather than 
climatic factors.
IntrOduCtIOn  
Countries in different regions of the world 
have reported seasonal fluctuations in tuber-
culosis (TB) cases.1–6 In temperate climate 
zones, peaks in TB diagnosis are generally 
observed in the spring, following the colder 
times of the year. The reasons for these varia-
tions are multiple, with both social and envi-
ronmental factors likely playing a role.7 Peaks 
in TB diagnosis following winter time have 
been associated with several factors: more 
strengths and limitations of this study
 ► We analysed a large dataset from HIV-positive
patients routinely collected over 10 years at
antiretroviral therapy (ART) programmes in low-
income and middle-income countries from the
Southern African region.
 ► Included ART programmes represent a wide range of 
countries with different climatic seasons according
to their geographical latitude.
 ► We compared trends in pulmonary tuberculosis
diagnosis to trends in Kaposi sarcoma and
extrapulmonary tuberculosis diagnoses, for which
no effect due to seasonal climatic changes was
expected.
 ► Our study is limited by the lack of social and
environmental information on participants
(socioeconomic factors and housing conditions).
 ► Trends in tuberculosis diagnosis and other
opportunistic infections in HIV-positive individuals
may differ from trends in HIV-negative populations.
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Table 1 Characteristics of participating ART programmes
Characteristics
South Africa, 
Khayelitsha
South Africa, 
Themba Lethu
South Africa, 
Tygerberg Zambia, CIDRZ
Zimbabwe, 
Newlands
Geographical 
latitude (°)
−34.05 −33.91 −26.12 −15.41 −17.81
Setting Urban Urban Urban Combination of urban and 
periurban health centres
Urban
Level of care Primary Secondary Tertiary Primary Primary
TB case 
definition
Majority 
microbiologically 
confirmed, others 
based on clinical 
presentation
Microbiologically 
confirmed
Majority 
microbiologically 
confirmed, others 
based on clinical 
presentation
Majority microbiologically 
confirmed, others based on 
clinical presentation
Majority 
microbiologically 
confirmed, others 
based on clinical 
presentation
Cost of TB 
diagnosis to 
patients
Available at no 
cost
Available at no 
cost
Partial payment Available at no cost or 
partial payment (depending 
on facility)
Available at no cost
Cotrimoxazole 
for prevention
All patients According to 
CD4 cell count
According to CD4 
cell count
According to CD4 cell count 
or to all patients (depending 
on facility)
According to CD4 cell 
count
Integration of 
HIV/TB clinical 
services
Same facility/
same day 
appointments
Same facility/
same day 
appointments
Cross-referral Cross referral Same facility/
same day 
appointments
TB screening 
at ART 
enrolment
All patients, 
symptomatic 
screening and 
diagnostic tests
All patients, 
symptomatic 
screening only
All patients, 
symptomatic 
screening only
All patients, symptomatic 
screening and diagnostic 
tests at selected sites
All patients, 
symptomatic 
screening only
Data sources: ref 15.
ART, antiretroviral therapy; CIDRZ, Centre for Infectious Disease Research in Zambia; TB, tuberculosis.
Figure 1 Selection of patients for the analysis. ART, antiretroviral therapy; CIDRZ, Centre for Infectious Disease Research in 
Zambia; PTB, pulmonary tuberculosis.
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time spent indoor in poorly ventilated rooms, which 
increases the risk of TB transmission; poorer access to 
healthcare when rough weather conditions make trans-
port difficult; and lower vitamin D levels due to reduced 
sunlight exposure, which impairs adequate immune 
response against infections.1 3 5 8–10 
In 2015, an estimated 1.2 million of people living with 
HIV developed TB, and one-third of them died from 
TB, making TB the leading cause of death in this popu-
lation.11–13 However, little is known about the seasonal 
variation of TB diagnoses among HIV-positive individuals 
in care at antiretroviral therapy (ART) programmes in 
sub-Saharan Africa, where the burden of HIV/TB coinfec-
tion is the highest.13 We hypothesised that fluctuations in 
TB diagnoses throughout the year would likely be stronger 
in countries located farther away from the equator and 
that experience more pronounced climatic changes, as 
opposed to countries located closer to the equator. We 
investigated seasonal trends in pulmonary TB (PTB) 
diagnosis at five ART programmes participating in the 
International Epidemiology Databases to Evaluate AIDS 
collaboration in Southern Africa (IeDEA-SA). These ART 
programmes are located at different geographical lati-
tudes in South Africa, Zambia and Zimbabwe and present 
differently marked climatic seasons.
MethOds
We included all HIV-positive persons aged ≥16 years who 
enrolled between 1 January 2004 and 31 December 2014 
in five ART programmes that participate in the IeDEA-SA 
collaboration (www. iedea- sa. org) and systematically 
collect information on opportunistic infections (OIs)14: 
Khayelitsha ART programme, Themba Lethu clinic and 
Tygerberg Academic Hospital in South Africa; Centre 
for Infectious Disease Research in Zambia (CIDRZ); and 
Newlands Clinic in Zimbabwe. IeDEA-SA sites provide 
data collected as part of routine HIV care, including 
TB diagnosis, at enrolment in the ART programme and 
at each follow-up visit. Site characteristics are shown in 
table 1,15 and the patient selection in figure 1.
All study sites have approval from a local institutional 
review board or ethics committee to collect data and 
participate in IeDEA-SA projects.
PTB was defined according to the case definition in 
use at the participating IeDEA-SA sites (table 1).15 We 
restricted the main analysis to PTB, because the diagnosis 
of PTB has been associated with seasonal climatic varia-
tions.1 2 7 For comparison, we analysed monthly counts 
of patients diagnosed with extrapulmonary tuberculosis 
(EPTB) and the AIDS-defining cancer Kaposi sarcoma 
(KS), which are not expected to be seasonal. One record 
Table 2 Characteristics of patients diagnosed with PTB between January 2004 and December 2014 compared with others
Characteristics Patients diagnosed with PTB Other patients All
Age at ART start (median, IQR), years 35 (30–41) 34 (29–41) 34 (29–41)
  Missing, n (%) 0 0 0
Gender, n (%)
 Woman 25 227 (51.1) 181 847 (64.4) 207 074 (62.4)
 Man 24 140 (48.9) 100 420 (35.6) 124 560 (37.6)
  Missing, n (%) 0 0 0
CD4 cell count at ART start (median, IQR), 
cells/µL
116 (52–200) 166 (87–254) 158 (80–246)
  Missing, n (%) 24 237 (48.8) 150 058 (53.2) 174 295 (52.6)
WHO clinical stage, n (%)
 Stages 1 and 2 4916 (9.9) 157 322 (55.7) 162 238 (48.9)
 Stages 3 and 4 41 744 (84.6) 106 836 (37.9) 148 580 (44.8)
 Unknown 2707 (5.5) 18 053 (6.4) 20 816 (6.3)
  Missing, n (%) 0 56 (0.02) 56 (0.02)
Treatment programme, n (%)
 South Africa, Khayelitsha 7357 (14.9) 25 021 (8.9) 32 378 (9.8)
 South Africa, Themba Lethu 5438 (11.0) 16 967 (6.0) 22 405 (6.8)
 South Africa, Tygerberg 861 (1.7) 3657 (1.3) 4518 (1.4)
 Zambia, CIDRZ 35 132 (71.2) 233 680 (82.8) 268 812 (81.1)
 Zimbabwe, Newlands 579 (1.2) 2942 (1.0) 3521 (1.1)
  Missing, n (%) 0 0 0
Total, n (%) 49 367 (14.9) 282 267 (85.1) 331 634 (100)
Missing values are indicated in italic. 
ART, antiretroviral therapy; CIDRZ, Centre for Infectious Disease Research in Zambia; PTB, pulmonary tuberculosis.
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per patient was analysed. If a patient had several episodes 
of the same disease (PTB, EPTB or KS), we only consid-
ered the first event of each. If a patient was diagnosed 
with multiple diseases of interest, priority was given to the 
record with PTB diagnosis, followed by EPTB and KS. We 
obtained mean monthly air temperatures (°C) based on 
1961–1990 averages at each location.16–19
For each site, we calculated aggregated averages as 
the average number of events per calendar month for 
2004–2014. We accounted for calendar time trends over 
the study period by comparing deviations of monthly 
event counts to yearly averages. Site-specific aggregated 
averages and monthly deviations were calculated for 
ART enrolments and for PTB, EPTB and KS diagnoses, 
overall or stratified by gender and age. We assessed the 
association between monthly deviations in the number of 
ART enrolments and the number of PTB diagnoses by 
calculating pairwise Pearson’s correlation coefficients.20 
We used Fisher’s transformation to calculate 95% CI for 
the correlation coefficient. Finally, we used linear regres-
sion models to assess associations between the monthly 
deviations of PTB, EPTB or KS diagnosis counts and the 
monthly deviations of ART initiation counts, unadjusted 
and adjusted for monthly deviations of air temperatures 
from yearly averages and for the geographical latitude of 
the ART programmes’ locations.
All analyses were performed in Stata V.14.1 (Stata 
Corporation, College Station, Texas, USA).
results
We analysed data of 331 634 HIV-positive adults (figure 1). 
Of these, 49 367 (14.9%) were diagnosed with PTB. The 
median follow-up time was 2.0 years (IQR, 0.7–4.2), 
patients’ median age was 34 years (IQR, 29–41) and 
207 074 (62.4%) were women (table 2). Median CD4 cell 
count at ART initiation of these patients was 116 cells/
mm3 (IQR, 52–200) in comparison with a median cell 
count of 166 (IQR, 87–254) in patients who were never 
diagnosed with PTB.
The mean number of PTB diagnoses per month was 
55.7 (range 40.2–67.8) in Khayelitsha, 41.2 (31.1–57.6) 
in Themba Lethu, 6.5 (3.8–7.7) in Tygerberg, 285.6 
(243.2–338.2) in CIDRZ and 4.8 (3.3–8.7) in Newlands 
(figure 2). At each site, monthly variations in numbers of 
PTB diagnoses were parallel to trends in ART enrolments. 
Aggregated averages over the study period showed that 
monthly fluctuations in PTB diagnoses were present at all 
Figure 2 Aggregated averages in monthly counts of patients newly started on ART and monthly counts of PTB diagnosis 
(aggregate averages 2004–2014, logarithmic scale). Dashed horizontal lines indicate overall monthly means. ART, antiretroviral 
therapy; PTB, pulmonary tuberculosis.
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sites (figure 2). The strongest fluctuations were seen in 
Zimbabwe (Newlands), with PTB diagnosis peaks in January 
and troughs in December (+87% and −33% compared with 
the monthly average, respectively). Similar to Zimbabwe, 
all three South African sites showed marked drops in ART 
initiations and PTB diagnoses in December, in addition to 
a milder drop in April–May. In contrast, Zambia (CIDRZ) 
showed little variation in ART enrolments and PTB diag-
noses throughout the year. We consistently observed a 
similar seasonal pattern in patients newly starting ART and 
PTB diagnoses every year (online supplementary figure 1), 
in men and women, as well as in younger and older patients 
(online supplementary figure 2).
The deviations of monthly event counts from the yearly 
averages confirmed the congruent fluctuations of ART initi-
ation and PTB diagnosis (online supplementary figure 3). 
This was further supported by the correlation coefficients 
between the deviations of monthly ART initiations from 
yearly averages and the deviations of monthly PTB diag-
noses from yearly averages (table 3): coefficient was 0.27 in 
Khayelitsha (95% CI 0.11 to 0.42, P=0.002), 0.22 in Themba 
Lethu (95% CI 0.05 to 0.38, P=0.010), 0.19 in Tygerberg 
(95% CI 0.02 to 0.35, P=0.028), 0.82 in CIDRZ (95% CI 
0.75 to 0.87, P<0.001) and 0.20 in Newlands (95% CI 0.02 
to 0.37, P=0.029). Regression coefficients between devia-
tions of monthly PTB diagnosis counts and monthly ART 
initiation counts from yearly averages did not substantially 
change when adjusted for monthly temperatures and lati-
tude (table 4). This was further supported by figure 3, 
which showed no evidence for a relationship between the 
adjusted regression coefficients and the latitude of the ART 
programme’s location (r=0.43, P=0.47).
To determine whether the diagnosis of other OIs 
followed trends similar to that of PTB and ART initiations, 
we studied the monthly diagnoses of EPTB and KS, which 
we did not expect to be influenced by climatic factors. The 
seasonal pattern of EPTB diagnoses paralleled that of ART 
initiation at most sites despite low numbers of EPTB diag-
noses (1.8–26.5 mean monthly EPTB diagnoses). The devi-
ations of monthly ART initiations from the yearly averages 
correlated with those of EPTB diagnoses in Khayelitsha, 
CIDRZ and Newlands (correlation coefficient range: 0.20–
0.54, table 3). Although KS was a rare diagnosis averaging 
1.1 cases per month overall, we observed that the fluctua-
tions in KS diagnosis counts similarly followed changes in 
ART enrolment at all sites (table 3). As for PTB diagnoses, 
the adjusted regression models did not support any influ-
ence of temperature or latitude on the observed fluctua-
tions in EPTB or KS diagnoses (table 4).
dIsCussIOn
We observed monthly variations in PTB diagnosis at ART 
programmes in South Africa, Zambia and Zimbabwe. 
These fluctuations occurred regardless of latitudes and 
followed trends in ART enrolment rather than seasonal 
variations in temperatures, hence mirroring fluctua-
tions in clinical activity. In South Africa and Zimbabwe, 
a marked drop of ART enrolments and PTB diagnoses 
was seen in December, followed by a rebound in January–
February. A milder drop was also observed in South 
African sites around April–May.
In Southern Africa, seasons are marked by cooler 
winters and warmer summers in Cape Town (Khayelitsha, 
Tygerberg), and become less pronounced as latitude 
decreases, in Johannesburg (Themba Lethu), Zimbabwe 
(Newlands) and Zambia (CIDRZ). Therefore, we expected 
to see stronger fluctuations in PTB diagnosis, with peaks 
following wintertime, in the Cape Town clinics situated at 
the Southern tip of South Africa, than in Johannesburg 
(Themba Lethu clinic), Zimbabwe (Newlands clinic) and 
Zambia (CIDRZ), where winter months are mild. Instead, 
Table 3 Correlation coefficients between deviations of monthly counts of ART enrolments from the yearly average and 
deviations of monthly counts of PTB, EPTB and KS diagnosis from the yearly averages
ART 
programme
ART  
enrolments PTB diagnoses EPTB diagnoses KS diagnoses
Median
(IQR)
Median
(IQR)
Correlation 
(95% CI) P value
Median 
(IQR)
Correlation 
(95% CI) P value
Median 
(IQR)
Correlation 
(95% CI) P value
South Africa, 
Khayelitsha
252 (236–265) 58 (46–64) 0.27  
(0.11 to 0.42)
0.002 26 (24–30) 0.20  
(0.03 to 0.36)
0.019 2 (1–2) 0.08  
(−0.11 to 0.25)
0.42
South Africa, 
Themba 
Lethu
171 (161–180) 41 (37–44) 0.22  
(0.05 to 0.38)
0.010 16 (14–17) 0.15  
(−0.03 to 0.31)
0.097 1 (1–1) 0.02  
(−0.16 to 0.19)
0.86
South Africa, 
Tygerberg
34 (34–37) 7 (6–8) 0.19  
(0.02 to 0.35)
0.028 3 (3–3) 0.09  
(−0.09 to 0.25)
0.33 0.3  
(0.2–0.5)
0.11  
(−0.06 to 0.28)
0.22
Zambia, 
CIDRZ
2163  
(2095–2233)
275  
(259–301)
0.82  
(0.75 to 0.87)
<0.001 9 (9–10) 0.54  
(0.40 to 0.65)
<0.001 29 (28–31) 0.68  
(0.57 to 0.77)
<0.001
Zimbabwe, 
Newlands
31 (29–34) 5 (4–6) 0.20  
(0.02 to 0.37)
0.029 2 (2–2) 0.23  
(0.06 to 0.40)
0.011 0.2  
(0.1–0.4)
0.22  
(0.05 to 0.39)
0.014
All 170 (34–264) 40 (6–63) 0.28  
(0.21 to 0.35)
<0.001 9 (3–17) 0.25  
(0.18 to 0.32)
<0.001 1 (0–2) 0.14  
(0.07 to 0.22)
<0.001
Median monthly event counts (2000–2014) and Pearson's pairwise correlation coefficients are shown.
ART, antiretroviral therapy; CIDRZ, Centre for Infectious Disease Research in Zambia; EPTB, extrapulmonary tuberculosis; KS, Kaposi sarcoma; PTB, 
pulmonary tuberculosis.
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we observed variations in PTB that seemed independent 
from climatic changes. This might be explained by mild 
winters in Southern Africa, contrasting with countries 
with harsh winters. Mongolia typically has cold winters 
and strong seasonal patterns in TB notifications, likely 
due to increased airborne transmission from infectious 
PTB individuals resulting from indoor crowding and 
poorer ventilation during winter.1 2 Nevertheless, seasonal 
variations in TB notifications in a population-based study 
of HIV-positive and HIV-negative individuals were docu-
mented in Cape Town, South Africa.8
We observed that variations in PTB diagnoses followed 
fluctuations in ART initiations regardless of temperatures 
and latitudes, and hence likely reflected activities at the 
clinic, rather than any climatic effects. This was supported 
by an association between changes in ART initiation 
and PTB diagnosis counts (unadjusted and adjusted for 
monthly climatic temperatures and latitude). Further-
more, important drops in ART initiations and PTB diag-
noses were observed every year in December in South 
Africa and Zimbabwe, when clinical activities are reduced 
due to the holiday season. December drops were followed 
by peaks in January and February, when clinical activity 
resumed. Similar declines in PTB diagnoses at the end of 
the year have been reported in Zimbabwe and Uganda 
by Mabaera et al.2 In CIDRZ, the largest of the cohorts, 
which we studied, monthly fluctuations in ART initiations 
and PTB diagnoses were the least marked, as compared 
with the South African and Zimbabwean sites. This can be 
explained by the shorter December holiday period in the 
Zambian health sector, in particular in the urban and peri-
urban region of Lusaka, where CIDRZ is based. There, the 
ART programmes continue to run over the festive season 
in December and are only closing on official public holi-
days. Furthermore, HIV-positive individuals seeking care 
at CIDRZ are mainly permanent residents in Lusaka city 
(as opposed to migrants from rural areas), and hence less 
likely to leave the city to visit their family in other parts 
of the country during holidays, which would contribute 
to delayed TB diagnoses. Similarly, Easter vacations likely 
explain the milder drop observed in April–May in South 
Africa, and to a lesser extend in Zimbabwe, but not in 
Zambia. Age and gender did not seem to influence the 
seasonal variations.
Table 4 Regression coefficients between deviations of monthly counts of PTB, EPTB or KS diagnoses and deviations of 
monthly counts of ART enrolments from the yearly averages (‘unadjusted for temperature’); adjusted for the deviations of 
monthly air temperatures to yearly average air temperatures at the ART programme (‘adjusted for temperature’)
ART programme
PTB diagnoses EPTB diagnoses KS diagnoses
Coefficient (95% CI) P value Coefficient (95% CI) P value Coefficient (95% CI) P value
South Africa, Khayelitsha
 Unadjusted for temperature 0.33 (0.13 to 0.53) 0.002 0.28 (0.05 to 0.51) 0.019 0.30 (−0.43 to 1.03) 0.416
 Adjusted for temperature 0.30 (0.09 to 0.51) 0.005 0.27 (0.03 to 0.51) 0.027 0.44 (−0.31 to 1.12) 0.248
South Africa, Themba Lethu
 Unadjusted for temperature 0.16 (0.04 to 0.28) 0.010 0.21 (−0.04 to 0.45) 0.097 0.07 (−0.74 to 0.88) 0.860
 Adjusted for temperature 0.17 (0.05 to 0.29) 0.005 0.21 (−0.03 to 0.46) 0.089 0.10 (−0.71 to 0.92) 0.805
South Africa, Tygerberg
 Unadjusted for temperature 0.41 (0.04 to 0.78) 0.028 0.20 (−0.20 to 0.60) 0.328 0.82 (−0.49 to 2.14) 0.218
 Adjusted for temperature 0.41 (0.05 to 0.78) 0.028 0.21 (−0.20 to 0.62) 0.307 0.92 (−0.39 to 2.23) 0.169
Zambia, CIDRZ
 Unadjusted for temperature 0.84 (0.74 to 0.95) <0.001 1.39 (1.00 to 1.78) <0.001 0.91 (0.73 to 1.08) <0.001
 Adjusted for temperature 0.83 (0.72 to 0.94) <0.001 1.40 (1.00 to 1.80) <0.001 0.90 (0.72 to 1.08) <0.001
Zimbabwe, Newlands
 Unadjusted for temperature 0.29 (0.03 to 0.54) 0.029 0.47 (0.11 to 0.83) 0.011 1.32 (0.27 to 2.38) 0.014
 Adjusted for temperature 0.29 (0.037 to 0.55) 0.025 0.47 (0.12 to 0.84) 0.010 1.31 (0.26 to 2.36) 0.015
All
 Unadjusted for temperature 
and latitude
0.37 (0.27 to 0.47) <0.001 0.50 (0.35 to 0.65) <0.001 0.75 (0.35 to 1.16) <0.001
 Adjusted for temperature 0.38 (0.28 to 0.48) <0.001 0.51 (0.36 to 0.66) <0.001 0.77 (0.36 to 1.18) <0.001
 Adjusted for temperature 
and latitude
0.38 (0.28 to 0.48) <0.001 0.51 (0.36 to 0.66) <0.001 0.77 (0.36 to 1.18) <0.001
The overall regression model was also adjusted for the latitude of the ART programme’s location (‘adjusted for temperature and latitude’). 
Monthly air temperatures are based on 1961–1990 averages.
ART, antiretroviral therapy; CIDRZ, Centre for Infectious Disease Research in Zambia; EPTB, extrapulmonary tuberculosis; KS, Kaposi 
sarcoma; PTB, pulmonary tuberculosis.
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EPTB and KS diagnoses also followed variations in ART 
initiations in our study. We did not expect the develop-
ment of EPTB to be strongly marked by climatic changes. 
Indeed, EPTB is less likely resulting from recent transmis-
sion than PTB, the transmission mode of which is airborne, 
and hence more likely to be influenced by indoor crowding 
and reduced ventilation during winter.1 7 Seasonal changes 
in EPTB case detection have been reported.3 4 21 However, 
the underlying reasons for EPTB seasonality may consider-
ably differ from those involved in PTB. In addition, EPTB 
is often underdiagnosed due to lack of adequate laboratory 
diagnostic tools in under-resourced settings.3 21 Similarly 
to EPTB, KS was not expected to be influenced by climatic 
factors. The observed seasonal fluctuations of EPTB and KS 
diagnoses hence reflect variations in clinical activities, such 
as observed for PTB.
Several explanations of why PTB diagnoses may vary 
seasonally have been offered.1 3 5 7–9 Beyond indoor 
crowding1 5 9 and reduced clinical activities at specific times 
during the year,2 health-seeking behaviour is also influ-
encing access to care. Health-seeking behaviour might 
reflect environmental barriers (long distances to the clinic 
and waiting time),22 23 psychological barriers (stigma)24 
and/or clinical barriers (poor patient’s health status and 
disabilities).25 Access to clinics can be problematic when 
temperatures are low and weather conditions are bad, 
which is more likely to be the case in places with harsh 
winters. Under these circumstances, PTB diagnosis might 
be delayed to spring. Professional activities or beliefs may 
also prevent early healthcare seeking. Economical aspects 
play an important role, where care is to be fully or partly 
paid by patients.15 These aspects might differently affect 
individuals, depending on gender or age.26–29 However, in 
our study populations, trends in ART initiations and PTB 
diagnoses were independent from gender or age. Finally, 
the role of vitamin D deficiency has been debated, and 
studies of the relationship between vitamin D deficiency 
during winter and PTB are inconsistent.3 30–32
Our study is limited by the possible underascertain-
ment of TB diagnoses at ART programmes and by the fact 
that we could only include IeDEA-SA sites that routinely 
collect information on OIs. However, the included ART 
programmes cover a wide range of geographical latitudes 
and different climatic seasons, with Khayelitsha and Tyger-
berg at the Southern tip and CIDRZ at the most equatorial 
end of the Southern African region. The findings of our 
study is restricted to HIV-positive populations, since trends 
in TB diagnosis and other OIs at ART programmes may 
differ from trends in HIV-negative populations. Due the 
high early TB mortality, HIV-positive individuals may not 
reach clinical care for a TB diagnosis.33 In addition, although 
ART reduces the risk of OIs significantly, people living with 
HIV remain at a higher risk of developing TB.34 35 Finally, 
social and environmental factors, including housing condi-
tions, distance to healthcare facilities, access to care, disease 
awareness and health-seeking behaviour, may differently 
Figure 3 Relationship between PTB diagnosis and geographical latitude: regression coefficients between deviations of 
monthly counts of PTB diagnoses and deviations of monthly counts of ART enrolments from the yearly averages (adjusted 
for air temperature) according to the geographical latitude of the ART programme’s location. ART, antiretroviral therapy ; PTB, 
pulmonary tuberculosis.
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affect the timely diagnosis of TB in HIV-positive compared 
with HIV-negative populations.1 7 9 36 37 Unfortunately, this 
information is not routinely collected at ART programmes 
in the IeDEA-SA collaboration.
COnClusIOns
In conclusion, our study suggests that yearly trends in 
PTB diagnosis at ART programmes in Southern Africa are 
mainly driven by seasonal variations in clinical activities, 
access to care and health-seeking behaviour, rather than 
climatic seasons. Our results underline the importance 
of offering regular care for HIV-infected individuals, 
including screenings for OIs such as TB at ART initiation 
and during follow-up visits, as part of integrated TB/HIV 
clinical activities at ART programmes.38–41
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